Relation of Red Cell Distribution Width with Thromboembolic Risk in Patients Had Non-valvular Atrial Fibrillation
Tarek Ahmed Naguib MD¹, Ahmed Mohamed Elzyat MD¹, Shimaa wageeh Mohamed MD¹, Ibrahim Elsayed Ahmed MBBch²
2- Dar elslam hospital
Corresponded: author [email protected]
Background: Higher red cell distribution width (RDW) anticipates harmful events in patients with cardiovascular diseases. On other hand, there is imperfect information concerning the association between RDW and thrombo-embolism hazard in the patients with atrial fibrillation. We intended to study the relation between RDW and CHA2DS2-VASc scores utilized for the assessment of thrombo-embolic hazard in patients with AF.
Methods: Our study enrolled 46 patients with AF. We calculated CHA2DS2-VASc score for every patient, and we investigate the laboratory and echocardiographic parameters. Depend on CHA2DS2-VASc scores; we classified the AF patients into two groups (low – intermediate risk and high risk groups). Then, we compared mentioned parameters between the 2 groups, and we assessed the relation between RDW and CHA2DS2-VASc score. Multivariate regression analysis was done to find independent indicators of high CHA2DS2-VASc scores.
Results: Patients with elevated CHA2DS2-VASc scores had older age and higher RDW, hs-CRP, creatinine serum level, left atrial diameter and intervetricular septum thickness comparably to the low CHA2DS2-VASc score group.Multivariate regression analysis appeared that RDW and hs-CRP were independent predictors for high CHA2DS2-VASc scores.
Conclusion: RDW is significantly associated with CHA2DS2-VASc score among patients with AF, as well as is an independent predictor in CHA2DS2-VASc score.
Introduction 🙁 reference, tong)
Risk of incidence cerebrovascular stroke and thrombo-embolism is incremented among patients with AF, which is considered the most common type of cardiac arrhythmia (1).nowadays, CHA2DS2-VASc score is suggested for assessment thromboembolic risk among patients with non-valvular AF (1). Red blood cell distribution width (RDW) defined as a quantum measure of size variability of circulating RBCs that may indicates inflammation and oxidative stress status. Lately, numerous studies have revealed that elevated RDW values predict adverse events among patients with heart failure, acute coronary syndrome and cerebrovascular ischemic stroke. Studies (2-4) on the relation between RDW and thrombo-embolic risk in AF are scantly. Our goal was to examine the relation between RDW and CHA2DS2-VASc scores which utilized for the assessment of thrombo-embolic risk among patients with AF.
A total of 46 successional patients who employed in our study between July 2017 and December 2017 .non-valvular atrial fibrillation defined as the absence of rheumatic mitral valve stenosis (more than mild mitral stenosis) and prosthetic heart valve in patient with atrial fibrillation. Inclusion criteria were at least one bout of symptomatic atrial fibrillation within the previous six months recorded by 12-lead electrocardiogram (ECG) (5). Patients with heart failure, mitral valve stenosis (more than mild MS), prosthetic heart valve, congenital heart disease, hypothyroidism, hyperthyroidism , anemia, malignancy, renal, hepatic impairment and acute or chronic inflammatory diseases were excluded from the study.in addition; patients who had a recent history (during preceding one month) of blood transfusion were also excluded.
In our study, we utilized CHA2DS2-VASc score for evaluate the risk of thrombo-embolism in patient non- valvular atrial fibrillation (Table 1). Therefore, a score of < 2 was considered as low-intermediate risk and ?2 was considered high risk. Full history taking , complete physical examination , laboratory examination ( CBC , creatinine , Na ,K, hs-CRP ) and cardiac investigations ( 12-lead ECG , transthoracic echocardiography ) were done on all patients. Every patient had at least one (12-lead ECG strip) revealed atrial fibrillation.
Complete blood count (CBC) testing was available using standard methods providing data on total lecuocytic count (TLC), hemoglobin (Hb) levels, platelets count and RDW on admission. RDW was calculated as the width of the RBC distribution curve at a relative height of 20% above the baseline by automatic blood count instrument measured in N100.000 RBC volume using an automated assay on samples obtained for standard of care. Assessment .The inter-run coefficient of variation of the RDW assay during the study period was routinely < 1%. Serum creatinine (Cr), potassium (K), and sodium (Na) were measured after overnight fasting (12 hr) using a TBA-120 FR analyzer. hs-CRP measurements were conducted by a Cobas Integra analyzer (Roche Diagnostics, Turkey) using the turbidimetric method.
A transthoracic echocardiographic examination was done in all patients via the Vivid-6 system equipped with a 2.2 MHz transducer (GE Medical Systems, Milwaukee, WI, USA) according to recent guidelines of The European Association of Cardiovascular Imaging (6). Left atrial diameters (LAD), interventricular septal thickness (IVST), left ventricular end-diastolic diameter (LVEDD), left ventricular end systolic diameter (LVESD) and left ventricular ejection- fraction (LVEF) were assessed. The Local Ethics Committee approved the study protocol while written informed consent was obtained from all patients.
Quantities variables were expressed as mean ± standard deviation, whereas qualitative variables were expressed as one hundredth values. Comparisons between the two groups were done via the Student t test or Mann-Whitney U test or chi-square tests. Multiple regression analysis done to detect the independent predictors of high CHA2DS2-VASc score. Receiver operating curve (ROC) analyses were utilized to identify the cut-off value of red cell distribution width in prediction of CHA2DS2-VASc score. Correlation analyses between variables were done via Pearson or Spearman correlation. A P- value of <.05 was considered significant. All statistical analysis was done via -SPSS 17.0 .Results:
The mean age of (46) patients employed in this study was (55.33±12.32) years, and 56.5% of the entire study population was female. High -CHA2DS2-VASc score group had higher red cell distribution width values, higher serum creatinine, higher hs-CRP, higher left atrium diameter and higher interventricular septum thickness versus to the low-intermediate CHA2DS2-VASc score group (Table 2).
According to the correlation analysis CHA2DS2-VASc score showed significant relationships with RDW ( r = 0.892 / p value 0.000 ), LA Diameter (r = 0.818/ p value 0.000) , IVST ( r = 0.488 p value 0.001), serum creatinine ( r = 0.648 / p value 0.021) , platelets count ( r = 0.294 / p value 0.04 ) and hs-CRP ( r = 0918 / p value 0.000).
Multi-variate regression analysis was done to predict high CHA2DS2-VASc scores revealed that RDW and hs-CRP were the most significant independent variable to predict thromboembolic risk in non valvular atrial fibrillation.
The best cut-off value of red cell distribution width to predict high CHA2DS2-VASc score was 13.4%. A RDW value higher than 13.4% has a sensitivity of 84% and a specificity of 90% (Figure 2).
Discussion: ( refrence kurt-disscussion )
The major finding of our study indicate that RDW values are significantly correlated with CHA2DS2-VASc score among patients who have non- valvular atrial fibrillation , while also being independent predictor of high CHA2DS2-VASc score. . A RDW value of >13.4 was predictive of an augmented CHA2DS2-VASc score with 84% sensitivity and 90% specificity.
Several thromboembolic risk factors that are components of the CHA2DS2-VASc scores such as peripheral vascular disease, hypertension, Diabetes, stroke have been associated with increased RDW levels. Thus, patient with lone AF had less RDW value, hs-CRP serum , Creatinine serum , left atrial diameter ( LAD) and interventricular septum thickness (IVST) than non-lone AF patients.
In addition, patients with RDW > 13.4 had higher left atrium diameter (LAD), interventricular septum thickness (IVST), serum creatinine and hs-CRP serum than patients with RDW < 13.4
According to multivariate regression examination revealed that most significant independent predictors of thrmbo-embolic risk among non-valvular atrial fibrillation patients were Red cell distribution width (RDW) and high sensitive C- reactive protein serum level (hs-CRP).
The prevalence of AF is a common, which could be increment mortality and morbidity especially in old age. Ischemic cerebro-vascular stroke is the most common serious form of thrombo-embolism that occurs on top of atrial fibrillation. (7-9) However, the occurrence of thrombo-embolism may depend on the coexisting clinical, echocardiographic, and laboratory parameters among patients with non-valvular atrial fibrillation. because that , multiple risk scoring systems have been created for the assessment of thrombo-embolism risk by investigating coexisting factors among patients with AF such as : clinical, echocardiographic and laboratory factors. (10-13). The CHA2DS2- VASc score is the most suggested risk scoring system for the evaluation of thrombo-embolism events . (5, 14).The association between RDW value and CHA2DS2-VASc score can be explained by several mechanisms. Firstly, as in intermountain risk score research, the researchers consider RDW values (after conducting of long term follow-ups) as one of thromboembolic predictors among patients with non-valvular AF. (15), some previous studies confirm that relation like Kurt study and Tong study. Secondly, patients with AF have higher C- reactive protein and BNP (brain natriuretic peptide) serum levels comparably to controls. (16-19)., inflammation and oxidative stress that occur in top of some risk factors such as (diabetes mellitus, hypertension, aging and heart failure) may affect erythrocyte maturation. So, immature RBCs (red blood cells) go in the blood circulation incrementing their relative proportion to mature RBCs leading to the remarkable heterogeneity in their size (3).
In the end, the relation between included risk factors in CHA2DS2-VASc score and RDW has been revealed by prior studies (20-23). RDW values are elevated among patients with heart failure comparably to control cases. While, the occurrence of adverse events among patients with heart failure are elevated in who had higher RDW values. (24, 25) In addition, RDW values are elevated among patients with history of cerebro-vascular ischemic stroke comparably to control cases. (20) Furthermore, elevated RDW is a significant predictor of cerebrovascular accidents in the general people and among patients who had cerebro-vascular ischemic stroke. (20) As well as, RDW has an association with diabetes and hypertension, (22, 23) So, Thrombo-embolism risk stratification is very important in terms of preventing adverse events in patients with AF.
We showed that RDW values were closely associated with thrombo-embolic risk assessed by CHA2DS2-VASc score among patients with atrial fibrillation. Consequently, it could be utilized with this score in thrombo-embolic risk stratification.in the end; we suggest more studies of multiple Centre study with larger number of patients needed in this setting.
Our study was a single Centre study with small number of patients. In addition, chronic asymptomatic inflammatory or infectious diseases prevalent in developing Countries could not be excluded, which could be affect (RDW) values. Furthermore, Difference between RDW in both groups in our study could be simply reflection of significant age difference between both groups.so, Further studies should be clarifyingTable (1): CHA2DS2-VASc score
Risk factor Score
Congestive heart failure / LV dysfunction 1
Diabetes mellitus 1
Previous stroke/TIA/thromboembolism 2
Vascular disease 1
Age 65-74 1
Sex female 1
Abbreviations: LV, left ventricle; TIA, transient ischemic attack.
risk (n =23) High risk
(n =23) p-value
Previous stroke 12 (52.2%)
46.96 ± 10.42
0 (0.0%) 14 (60.9%)
63.70 ± 7.46
11 (47.8%) 0.552
Peripheral vascular dis.
Lone AF 0 (0.0%)
17 (73.9%) 7 (30.4%)
0 (0.0%) 0.000
LAD(cm) 3.85 ± 0.37 4.93 ± 0.84 0.000
LVEF (%) 63.39 ± 8.37 63.38 ± 9.86 0.997
IVST(cm) 0.99 ± 0.14 1.22 ± 0.26 0.027
LVEDD(cm) 4.95 ± 0.55 5.00 ± 0.92 0.799
Createnine(mg/dl) 0.81 ± 0.24 1.17 ± 0.23 0.030
K (mmol/l) 139.61 ± 4.58
4.03 ± 0.41 140.70 ± 4.88
4.00 ± 0.36 0.440
TLC(x10?) 8.17 ± 1.43 8.86 ± 1.53 0.123
Hb(gm/dl) 14.27 ± 1.45 13.83 ± 1.07 0.249
RDW (cv %)
12.34 ± 0.56
184.83 ± 68.16
2.60 ± 1.8 14.47 ± 0.59
226.57 ± 81.90
9.99 ± 2.32 0.000
Parameters CHAD2VASC2 SCORE
Age (years) 0.704** 0.000
LAD(cm) 0.818** 0.000
LVEF (%) -0.180 0.233
IVST(cm) 0.488** 0.001
LVEDD(cm) 0.024 0.874
creatinine(mg/dl) 0.648** 0.021
Na(mmol/l) 0.105 0.489
K(mmol/l) -0.013 0.929
TLC(x10?/l) 0.380** 0.119
HB(gm/dl) -0.123 0.414
RDW (cv %) 0.892** 0.000
platelets(x10?/l) 0.294* 0.048
hs-CRP(mg/dl) 0.918** 0.000
Variable ? OR P-VALUE RDW 5.146 171.752 0.002 Createnine 1.450 4.262 0.237 LAD 2.271 4.688 0.120 hs-CRP 3.472 32.197 0.017